Multiple Myeloma (MM) is a type of cancer that affects the blood. This study, called the Connect® MM Registry, looks at how doctors treat MM and how it affects patients. The study includes people who are newly diagnosed and those who have had MM treatment before.

To join, you must be 18 or older and have been diagnosed with MM recently or have had treatment and your disease is getting worse. You need to agree to answer questions about your health. If you had treatment for a less severe form of MM called smoldering MM or MGUS, you cannot join this study.

• The study involves filling out questionnaires, possibly with some help.
• Participation can start within 2 months of diagnosing MM or 90 days of starting new treatment.
• It's important not to be in any other MM study while participating in this one.

This study will help doctors understand MM better and improve treatment for future patients. If you're eligible and agree to the terms, you can contribute to this important research.